Patents by Inventor Soeren Skov Jensen

Soeren Skov Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable Semaglutide compositions and uses thereof
    Publication number: 20240415934
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising a stabilizer such as histidine, their preparation, kits comprising such compositions as well as medical uses thereof.
    Type: Application
    Filed: August 26, 2024
    Publication date: December 19, 2024
    Inventors: Dorthe Kot Engelund, Soeren Skov Jensen, Joakim Lundqvist
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE
    Publication number: 20230165939
    Abstract: The invention relates to stabilised solid pharmaceutical compositions comprising a GLP-1 agonist. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 1, 2023
    Inventors: Soeren Skov Jensen, Robert James Dancer, Louise Thorstholm, Morten Hach
  • METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS
    Publication number: 20230089196
    Abstract: The invention relates to methods for the quantification of glycoproteins in a sample, comprising quantifying said glycoproteins by comparison with an internal standard, wherein said internal standard comprises variant forms of said glycoproteins, wherein said variant forms contain only core Asn-linked GlcNAc moieties.
    Type: Application
    Filed: February 19, 2021
    Publication date: March 23, 2023
    Inventors: Ewald T.J. VAN DEN BREMER, Sipke SANGERS, Demelza WILLEMSZ, Richard G. HIBBERT, Rob N. DE JONG, Søren Skov JENSEN, Emil POULSEN
  • STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF
    Publication number: 20210379159
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising a stabilizer such as histidine, their preparation, kits comprising such compositions as well as medical uses thereof.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 9, 2021
    Inventors: Dorthe Kot Engelund, Soeren Skov Jensen, Joakim Lundqvist